February 14, 2007 – 6:38 am
A large-scale analysis of data on breast cancer risk has concluded that a common variation in the gene caspase-8 (CASP8) is associated with a somewhat lower risk of the disease. Variants are small changes that occur in a gene sequence. The results are from the second study published by the Breast Cancer Association Consortium (BCAC), […]
February 14, 2007 – 6:26 am
The new drug exemestane for breast cancer treatment could improve survival rates by 17 percent, new research shows.
A study of 4,742 post-menopausal women found that switching from the present gold-standard breast cancer treatment tamoxifen to the new drug exemestane after two or three years resulted in a dramatic fall in death rates, The Times newspaper […]
February 11, 2007 – 10:26 pm
Women with early-stage breast cancer might soon get another gene test to help predict whether they’ll relapse within five or 10 years, information that could influence how aggressively they fight the initial tumor.
The MammaPrint test isn’t the nation’s first such predictor for breast cancer — a competitor has been sold since 2004 — but on […]
February 8, 2007 – 4:14 pm
Use of growth factors with chemotherapy for breast cancer could increase risk of leukemia.
Chemotherapy often depletes the white blood cells, making patients vulnerable to infection. That is why growth factors such as granulocyte-colony stimulating factor are often used to protect the cells. But researchers at Columbia University now report that such growth factors, used with […]
February 8, 2007 – 3:57 pm
KARACHI: US regulators have approved a new diagnostic tool to help target treatment for breast cancer patients, Nature.com reported Wednesday.
The test, called MammaPrint and produced by the Dutch company Agendia, uses the expression of 70 genes in tumour samples to help determine whether a woman with early-stage cancer is likely to suffer from a recurrence, […]
